Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

1.4K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen Species.

ACS infectious diseases·2026
Same author

The immunoproteasome regulates ILC2 responses by modulating mitochondrial capacity.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

The Insomnia EEG Score: a new tool for the classification of people with poor sleep.

Sleep·2025
Same author

<i>Mycobacterium tuberculosis, Mycobacterium kansasii</i> and <i>Rhodococcus equi</i> induce macrophage necroptosis in the presence of a caspase inhibitor acting on a non-canonical target(s).

bioRxiv : the preprint server for biology·2025
Same author

Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl Transferase.

Journal of medicinal chemistry·2025
Same author

Tuberculosis in otherwise healthy adults with inherited TNF deficiency.

Nature·2024

Related Experiment Video

Updated: May 2, 2026

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

12.0K

Benzimidazole-based compounds kill Mycobacterium tuberculosis.

Yaling Gong1, Selin Somersan Karakaya2, Xiaoyong Guo1

  • 1Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, 2A Nanwei Road, Xuanwu District, Beijing 100050, PR China.

European Journal of Medicinal Chemistry
|February 22, 2014
PubMed
Summary
This summary is machine-generated.

New benzimidazole-based compounds show potent activity against tuberculosis (TB). Compound 70, with a 5-nitrofuranyl group, is a promising candidate for developing novel anti-TB drugs.

Keywords:
BenzimidazoleDrugMycobacterium tuberculosisNitrofuranTuberculosis

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K

Related Experiment Videos

Last Updated: May 2, 2026

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

12.0K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Tuberculosis (TB) is a major global health threat, causing millions of deaths annually.
  • Increasing drug resistance in Mycobacterium tuberculosis (Mtb) necessitates the development of new antibiotics.
  • Existing treatments face challenges due to drug resistance and toxicity.

Purpose of the Study:

  • To design, synthesize, and evaluate novel benzimidazole-based compounds for anti-TB activity.
  • To investigate the structure-activity relationships (SAR) of these compounds against Mtb.
  • To identify potent and safe drug candidates for further development.

Main Methods:

  • Synthesis of a series of benzimidazole-based compounds.
  • Antimicrobial susceptibility testing against replicating and non-replicating Mtb.
  • Cytotoxicity assays to determine selectivity indices (SI).
  • Intra-macrophage killing assays and mutagenicity testing (SOS Chromotest).

Main Results:

  • Several compounds, particularly those with a 5-nitrofuranyl moiety (e.g., compounds 49, 67-70, 72), demonstrated high potency against Mtb.
  • Compound 70 exhibited excellent activity (MIC90 < 0.049 μg/mL) and a high SI (> 512).
  • The 5-nitrofuranyl group showed good intra-macrophage activity and low cytotoxicity but lacked activity against non-replicating Mtb.

Conclusions:

  • Benzimidazole derivatives, especially those incorporating a 5-nitrofuranyl group, represent a promising class of compounds for novel anti-TB drug development.
  • Compound 70 is a strong candidate for further investigation due to its potent activity, low cytotoxicity, and low mutagenic potential.
  • Further research is warranted for target identification and optimization of these compounds for treating tuberculosis.